New Investigator Awardee - January 29, 2016
Posters & IRR - January 29, 2016
Pharma Pipelines - February 12, 2016
Log in to see the ePosters from the 2015 ASCP Annual Meeting
Join ASCP today and become part of an organization dedicated to advance the science and practice of clinical psychopharmacology. Members benefits from discounted registration to ASCP’s Annual Meeting, Psychopharmacology Update and Clinical Trials Workshop.
The 2016 ASCP Annual Meeting will take place in Scottsdale, AZ from May 31 - June 3, 2016. The meeting will include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Steering Committee chaired by Drs. Husseini Manji and Michael Thase with representation of the sectors that are part of the ASCP community led the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, the pharmaceutical industry and academia comprise the 2016 Steering Committee. A Program Committee under the leadership of Drs. Holly Swartz and Alan Gelenberg were responsible for review of all program submissions.
We look forward to seeing you at the 2016 ASCP Annual Meeting, May 31 - June 3, 2016 in Scottsdale, AZ!